$3.61
-6.5%3D Systems Corporation, through its subsidiaries, provides 3D printing and digital manufacturing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers 3D printers, such as stereolithography, selective laser sintering, direct metal printing, multi jet printing, color jet printing, and extrusion and SLA based bioprinting that transform digital data input generated by 3D design software, computer aided design (CAD) software, or other 3D design tools into printed parts. It also develops, blends, and markets various print materials, such as plastic, nylon, metal, composite, elastomeric, wax, polymeric dental, and bio-compatible materials. In addition, the company provides digital design tools, including software, scanners, and haptic devices, as well as solutions for product design, simulation, mold and die design, 3D scan-to-print, reverse engineering, production machining, metrology, and inspection and manufacturing workflows under the Geomagic brand. Further, it offers 3D Sprint and 3DXpert, a proprietary software to prepare and optimize CAD data and manage the additive manufacturing processes, which provides automated support building and placement, build platform management, print simulation, and print queue management; and Bioprint Pro, a software solution that allows researchers to design and bioprint repeatable experiments. Additionally, the company provides maintenance and training services; manufacturing services; and software and precision healthcare services. It primarily serves companies and small and midsize businesses in medical, dental, automotive, aerospace, durable good, government, defense, technology, jewelry, electronic, education, consumer good, energy, biotechnology, and other industries through direct sales force, channel partners, and appointed distributors. 3D Systems Corporation was founded in 1986 and is headquartered in Rock Hill, South Carolina.
Co-Founder, Executive Vice President, Chief Technology Officer of Regenerative Medicine & Director Emeritus
Executive Vice President of Additive Solutions & Chief Commercial Officer
Compensation
$562,577
Executive Vice President of Engineering & Operations
Compensation
$431,958
Executive Vice President, Chief People Officer & Chief Administrative Officer
Compensation
$486,362
Executive Vice President, Principal Accounting Officer & Chief Financial Officer
Compensation
$427,515
President - Regenerative Medicine
President, Chief Executive Officer & Director
Compensation
$874,694
Senior Vice President of General Counsel & Corporate Secretary
Treasurer & Vice President of Investor Relations
During the last 12 months, insiders have sold $185K worth of DDD shares, with no buying activity reported.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
87.1K
184.61K
-185K
-$185K
No buying activity
Graves Jeffrey A
Director, Officer: President And Ceo
$85K
Puthenveetil Reji
Officer: Evp, Additive Solutions & Cco
$34K
Nordstrom Phyllis B
Officer: Evp Cpo, Cao & Interim Cfo
$28K
Zuiker Joseph R.
Officer: Evp, Engineering & Operations
$14K
Wright Andrew William Banasick
Officer: Svp, Gc & Secretary
$12K
Strong bearish signal with $185K net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
DDD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 08, 2026 | May 14, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 04, 2025 | May 16, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | August 13, 2024 | August 30, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 05, 2023 | April 05, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 11, 2022 | May 24, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | April 08, 2021 | May 18, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 07, 2020 | May 19, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 29, 2019 | May 21, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 28, 2018 | May 15, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 29, 2017 | May 16, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.